TARA Protara Therapeutics, Inc. - Common Stock
$3,94
Cena · Sie 18, 2026
Dane fundamentalne na dzień Sie 11, 2026
Zakres 52 tyg.
$3–$8
20% of range
Ocena Analityków
BUY
14 analysts
Cena Docelowa
$27
+575% upside
P/E (TTM)
-2.9
ROE
-33.7%
Marża Zysku Netto
—
O Protara Therapeutics, Inc. - Common Stock Przegląd firmy z Wikipedii
Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri.
Czytaj więcej
Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri.
Company History
Proteon was founded by Dr. F. Nicholas Franano based on technology created at Johns Hopkins University. Major investors in the company include MPM Capital, Rockhill Partners, TVM Capital, Skyline Ventures, Prism VentureWorks, Vectis Life Sciences and Intersouth Partners. They have invested over $72 million in the company.
The company is led by Timothy Noyes, CEO; Steven Burke, CMO; George Eldridge, CFO; and Scott Toner, director of marketing.
On March 5, 2009, the company announced that it had raised $32 million from its existing investors plus MPM Capital and Vectis Life Sciences. Proteon also announced that it had entered into an option agreement to be acquired by Novartis for up to $550 million. The company went public in 2014.
In September 2019, Proteon Therapeutics merged with ArTara Therapeutics.
PRT-201
Proteon is developing PRT-201 (vonapanitase), a drug to improve blood flow following vascular surgery procedures, and, more broadly, is interested in vascular access for hemodialysis and peripheral arterial disease (PAD). PRT-201 is a recombinant human elastase manufactured for Proteon by Lonza.
In September 2008, the company announced that the Food and Drug Administration had granted fast track status to PRT-201.
In December 2016, they announced that the phase III trial of PRT-201 hadn't reached its primary endpoint, causing Proteon's stock price to drop more than 75%.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
TARA Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$3.94
Kapitalizacja Rynkowa
$211M
P/E (TTM)
-2.9
EPS (TTM)
$-1.34
Przychody (TTM)
—
Stopa dywidendy
—
ROE
-33.7%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$3 – $8
TARA Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
—
EPS
$-1.34
2021-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-56M
2016-12-31
→
2025-12-31
Marże
—
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
TARA
Mediana porównawcza
P/E (TTM)
-2.9
88.5
P/B
1.1
3.6
Price / FCF (Cena / FCF)
-3.7
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
TARA
Mediana porównawcza
ROA
-29.4%
-38.8%
ROE
-33.7%
-61.0%
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
TARA
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
14.6
3.9
Quick Ratio (Wskaźnik Szybkości)
14.2
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
TARA
Mediana porównawcza
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
TARA
Mediana porównawcza
TARA Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
14 analityków
- Mocne kupno 3 21,4%
- Kup 10 71,4%
- Trzymaj 1 7,1%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
7 analityków · 2026-08-13
Mediana
$26.00
Średnia
$26.57
← Poniżej wszystkich celów
$3.94
Niski
$24.00
Wysoki
$30.00
Średni cel
$26.00
+560,7%
Średnia cel
$26.57
+575,3%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.07%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $-0.31 | $-0.38 | 0.07% |
| 31 grudnia 2025 | $-0.37 | $-0.33 | -0.04% |
| 30 września 2025 | $-0.31 | $-0.39 | 0.08% |
| 30 czerwca 2025 | $-0.35 | $-0.41 | 0.06% |
| 31 marca 2025 | $-0.29 | $-0.46 | 0.17% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| TARA | $286M | -4.0 | — | — | -33.7% | — |
| CNXU | — | — | — | — | — | — |
| GLSI | $300M | -14.7 | — | — | -2159.7% | — |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | — |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | — |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | — |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | — |
| NBP | — | — | — | — | — | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| R&D Expense | $43M | $32M | $25M | $17M | $21M | $12M | $4M | $12M | $22M | $19M | $12M | $6M | |
| SG&A Expense | $22M | $17M | $19M | $21M | $26M | $22M | $4M | $10M | $9M | $10M | $8M | $4M | |
| Operating Expenses | $65M | $49M | $44M | $67M | $47M | $34M | $8M | $21M | $30M | $29M | $21M | $11M | |
| Operating Income | $-65M | $-49M | $-44M | $-67M | $-47M | $-34M | $-8M | $-21M | $-30M | $-29M | $-21M | $-8M | |
| Interest Expense | · | · | · | · | $0 | $34.0K | · | · | · | · | · | $857.0K | |
| Interest Income | $6M | $4M | $3M | $1M | $237.0K | $500.0K | · | · | · | · | · | · | |
| Other Non-op | $7M | $5M | $3M | $1M | $237.0K | $466.0K | · | $207.0K | $139.0K | $-14.0K | $-651.0K | $5M | |
| Pretax Income | $57M | $45M | · | · | · | · | $-15M | $-21M | $-30M | $-29M | $-21M | $-3M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | $-110.0K | |
| Net Income | $-57M | $-45M | $-40M | $-66M | $-47M | $-34M | $-8M | $-21M | $-30M | $-29M | $-21M | $-3M | |
| EPS (Basic) | $-1.34 | $-2.17 | $-3.57 | $-5.86 | $-4.21 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.34 | $-2.17 | $-3.57 | $-5.86 | $-4.21 | · | · | · | · | · | · | · | |
| Shares (Basic) | 42,836,129 | 20,592,847 | 11,331,338 | 11,259,615 | · | · | · | · | · | · | · | · | |
| Shares (Diluted) | 42,836,129 | 20,592,847 | 11,331,338 | 11,259,615 | 11,232,576 | · | · | · | · | · | · | · | |
| EBITDA | $-65M | $-49M | $-44M | $-67M | $-47M | $-34M | $-15M | · | · | $-29M | $-21M | $-8M |
Bilans 23
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $50M | $163M | $40M | $24M | $36M | $169M | $564.0K | $19M | $21M | $36M | $40M | $69M | |
| Short-term Investments | $106M | $7M | $26M | $60M | $56M | · | · | $2M | $21M | $5M | $25M | $15M | |
| Prepaid Expense | $4M | $2M | $3M | $2M | $2M | $787.0K | $78.0K | $1M | $1M | $1M | $1M | $1M | |
| Other Current Assets | $65.0K | $2.0K | $37.0K | $127.0K | $34.0K | $52.0K | · | · | · | · | · | · | |
| Current Assets | $160M | $172M | $69M | $86M | $93M | $169M | $764.0K | $23M | $43M | $43M | $67M | $85M | |
| PP&E (Net) | $759.0K | $1M | $1M | $2M | $2M | $1M | $459.0K | $263.0K | $259.0K | $372.0K | $224.0K | $83.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $1M | $475.0K | $1M | $971.0K | $937.0K | $665.0K | $467.0K | |
| Accum. Depreciation | $1M | $1M | $824.0K | $483.0K | $236.0K | $119.0K | $16.0K | $827.0K | $712.0K | $565.0K | $441.0K | $384.0K | |
| Goodwill | · | · | · | · | $30M | $30M | · | · | · | · | · | · | |
| Other Non-current Assets | $20.0K | $27.0K | $11.0K | $16.0K | $865.0K | $1M | · | · | $218.0K | $393.0K | $706.0K | $114.0K | |
| Total Assets | $209M | $181M | $79M | $113M | $173M | $203M | $1M | $24M | $44M | $44M | $68M | $85M | |
| Accounts Payable | $3M | $4M | $2M | $2M | $954.0K | $914.0K | $716.0K | $441.0K | $291.0K | $556.0K | $1M | $917.0K | |
| Accrued Liabilities | $6M | $5M | $3M | $3M | $2M | $2M | $3M | $3M | $9M | $5M | $3M | $1M | |
| Current Liabilities | $11M | $11M | $6M | $6M | $4M | $3M | $3M | $3M | $9M | $5M | $4M | $2M | |
| Capital Leases | $2M | $3M | $4M | $5M | $6M | $999.0K | · | · | · | · | · | · | |
| Total Liabilities | $13M | $14M | $11M | $11M | $11M | $4M | $3M | $3M | $9M | $5M | $4M | $2M | |
| Common Stock | $54.0K | $35.0K | $11.0K | $11.0K | $11.0K | $11.0K | $3.0K | · | $18.0K | $17.0K | $16.0K | $16.0K | |
| Paid-in Capital | $499M | $412M | $269M | $263M | $256M | $246M | $11M | $209M | $203M | $198M | $195M | $192M | |
| Retained Earnings | $-302M | $-245M | $-200M | $-160M | $-94M | $-47M | $-13M | $-210M | $-190M | $-160M | $-131M | $-110M | |
| AOCI | $90.0K | $2.0K | $-31.0K | $-688.0K | $-211.0K | · | $3.0K | $5.0K | $-14.0K | · | $-11.0K | $-6.0K | |
| Stockholders' Equity | $196M | $167M | $68M | $102M | $162M | $199M | $-2M | $5M | $35M | $38M | $63M | $82M | |
| Liabilities + Equity | $209M | $181M | $79M | $113M | $173M | $203M | $1M | $24M | $44M | $44M | $68M | $85M | |
| Shares Outstanding | 53,587,260 | 35,044,772 | 11,364,903 | 11,267,389 | 11,235,731 | 11,211,840 | 2,627,533 | 481,091 | 17,674,729 | 16,603,559 | 16,501,500 | 16,448,455 |
Przepływy pieniężne 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | $123.0K | $57.0K | $30.0K | |
| Stock-based Comp | $4M | $4M | $6M | $7M | $10M | $10M | $424.0K | $3M | $3M | $3M | $2M | $459.0K | |
| Deferred Tax | $-11M | $-20M | $-14M | $-9M | $-5M | $-9M | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | · | · | $3M | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $1M | $2M | $-7M | |
| Operating Cash Flow | $-56M | $-36M | $-38M | $-26M | $-35M | $-23M | $-5M | $-23M | $-22M | $-24M | $-18M | $-10M | |
| CapEx | $94.0K | $63.0K | $45.0K | $120.0K | $596.0K | $884.0K | $475.0K | $119.0K | $35.0K | $271.0K | $198.0K | $51.0K | |
| Investing Cash Flow | $-139M | $19M | $53M | $15M | $-98M | $3M | $-475.0K | $18M | $-16M | $20M | $-11M | · | |
| Stock Issued | · | · | · | · | · | $74M | · | · | · | · | · | $62M | |
| Stock Repurchased | · | · | $91.0K | $90.0K | $228.0K | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | $-91.0K | $-90.0K | $-228.0K | $66M | · | · | · | · | · | $62M | |
| Financing Cash Flow | $83M | $140M | $-91.0K | $-90.0K | $-228.0K | $189M | $500.0K | $3M | $23M | $208.0K | $163.0K | · | |
| Net Change in Cash | · | · | · | · | · | · | $-13M | $-2M | $-15M | $-4M | $-29M | $66M | |
| Free Cash Flow | $-56M | $-36M | $-38M | $-27M | $-35M | $-24M | $-16M | · | · | $-24M | $-18M | $-10M |
Rentowność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -7391.4% | · | · | · | · | · | -257.1% | |
| Net Margin | · | · | · | · | · | -7291.4% | · | · | · | · | · | -113.4% | |
| EBITDA Margin | · | · | · | · | · | -7391.4% | · | · | · | · | · | -256.1% | |
| ROA | -29.4% | -34.2% | -42.0% | -46.1% | -25.1% | -33.2% | -98.3% | · | · | -51.4% | -28.1% | -7.4% | |
| ROE | -33.7% | -35.8% | -55.6% | -54.7% | -28.4% | -17.2% | -449.1% | · | · | -56.0% | -29.3% | 37.0% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.6 | 15.7 | 11.2 | 15.0 | 21.7 | 58.1 | 12.0 | · | · | 8.4 | 16.1 | 36.2 | |
| Quick Ratio | 14.2 | 15.5 | 10.7 | 14.7 | 21.2 | 57.8 | 10.6 | · | · | 8.1 | 15.8 | 35.8 | |
| Interest Coverage | · | · | · | · | · | -1013.1 | · | · | · | · | · | -8.8 |
Efektywność 1
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | · | · | · | · | · | 0.1 |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Net Income TTM | $-57M | $-45M | $-40M | $-66M | $-47M | $-34M | $-8M | $-21M | $-30M | $-29M | $-21M | $-3M | |
| Market Cap | $286M | $185M | $21M | $30M | $76M | $271M | $9M | · | · | $1.26B | $10.24B | $6.84B | |
| P/E | -4.0 | -2.4 | -0.5 | -0.5 | -1.6 | · | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | 2321.1 | |
| P/B | 1.5 | 1.1 | 0.3 | 0.3 | 0.5 | 1.4 | 1.4 | · | · | 32.8 | 161.5 | 83.0 | |
| P / Tangible Book | 1.5 | 1.1 | 0.3 | 0.3 | 0.6 | 1.6 | · | · | · | · | · | · | |
| P / Cash Flow | -5.1 | -5.2 | -0.6 | -1.1 | -2.2 | -11.6 | -0.6 | · | · | -53.3 | -582.8 | -684.9 | |
| P / FCF | -5.1 | -5.2 | -0.6 | -1.1 | -2.2 | -11.2 | -0.6 | · | · | -52.7 | -576.3 | -681.5 | |
| Earnings Yield | -25.1% | -41.1% | -190.4% | -218.7% | -62.4% | · | · | · | · | · | · | · |
Rachunek zysków i strat 12
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $17M | $14M | $13M | $10M | $11M | $9M | $9M | $8M | $6M | $8M | $6M | $6M | $7M | $5M | $5M | $3M | |
| SG&A Expense | $6M | $6M | $6M | $5M | $6M | $5M | $5M | $4M | $4M | $4M | $5M | $4M | $5M | $5M | $5M | $5M | |
| Operating Expenses | $23M | $20M | $19M | $15M | $17M | $14M | $14M | $12M | $11M | $12M | $11M | $11M | $12M | $10M | $40M | $8M | |
| Operating Income | $-23M | $-20M | $-19M | $-15M | $-17M | $-14M | $-14M | $-12M | $-11M | $-12M | $-11M | $-11M | $-12M | $-10M | $-40M | $-8M | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $756.0K | $820.0K | $840.0K | $846.0K | $687.0K | $542.0K | $283.0K | |
| Other Non-op | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $756.0K | $820.0K | $840.0K | $846.0K | $687.0K | $542.0K | $283.0K | |
| Net Income | $-22M | $-18M | $-17M | $-13M | $-15M | $-12M | $-13M | $-11M | $-10M | $-11M | $-10M | $-10M | $-11M | $-9M | $-39M | $-8M | |
| EPS (Basic) | $-0.36 | $-0.31 | $-0.39 | $-0.31 | $-0.35 | $-0.29 | $-0.25 | $-0.50 | $-0.45 | $-0.97 | $-0.90 | $-0.87 | $-1.00 | $-0.80 | $-3.46 | $-0.68 | |
| EPS (Diluted) | $-0.36 | $-0.31 | $-0.39 | $-0.31 | $-0.35 | $-0.29 | $-0.25 | $-0.50 | $-0.45 | $-0.97 | $-0.90 | $-0.87 | $-1.00 | $-0.80 | $-3.46 | $-0.68 | |
| Shares (Basic) | 61,006,766 | 57,538,833 | -82,414,767 | 42,272,104 | 42,270,855 | 40,707,937 | -34,391,036 | 22,329,772 | 21,233,163 | 11,420,948 | -22,628,260 | 11,347,887 | 11,307,842 | 11,303,869 | -22,511,202 | 11,265,475 | |
| Shares (Diluted) | 61,006,766 | 57,538,833 | -82,414,767 | 42,272,104 | 42,270,855 | 40,707,937 | -34,391,036 | 22,329,772 | 21,233,163 | 11,420,948 | -22,628,260 | 11,347,887 | 11,307,842 | 11,303,869 | -22,511,202 | 11,265,475 | |
| EBITDA | $-23M | $-20M | · | $-15M | $-17M | $-14M | · | $-12M | $-11M | $-12M | · | $-11M | $-12M | $-10M | · | $-8M |
Bilans 23
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17M | $15M | $50M | $13M | $31M | $91M | $163M | $52M | $90M | $52M | $40M | $34M | $34M | $21M | $24M | $47M | |
| Short-term Investments | $125M | $121M | $106M | $120M | $91M | $33M | $7M | $30M | · | $3M | $26M | $40M | $46M | $66M | $60M | $49M | |
| Prepaid Expense | $4M | $4M | $4M | $3M | $3M | $2M | $2M | $4M | $3M | $3M | $3M | $4M | $4M | $8M | $2M | $2M | |
| Other Current Assets | $230.0K | $17.0K | $65.0K | $218.0K | $78.0K | $16.0K | $2.0K | $3.0K | $4.0K | $3.0K | $37.0K | $2.0K | $1.0K | $127.0K | $127.0K | · | |
| Current Assets | $146M | $140M | $160M | $136M | $125M | $127M | $172M | $85M | $92M | $58M | $69M | $78M | $84M | $95M | $86M | $99M | |
| PP&E (Net) | $1M | $669.0K | $759.0K | $828.0K | $912.0K | $988.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | |
| Accum. Depreciation | · | · | $1M | · | · | · | $1M | · | · | · | $824.0K | · | · | · | $483.0K | · | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $30M | |
| Other Non-current Assets | $74.0K | $76.0K | $20.0K | $21.0K | $29.0K | $35.0K | $27.0K | $33.0K | $19.0K | $31.0K | $11.0K | $3M | $3M | $586.0K | $16.0K | $734.0K | |
| Total Assets | $176M | $192M | $209M | $145M | $157M | $169M | $181M | $94M | $102M | $68M | $79M | $88M | $95M | $106M | $113M | $149M | |
| Accounts Payable | $5M | $4M | $3M | $5M | $5M | $2M | $4M | $2M | $1M | $972.0K | $2M | $3M | $2M | $4M | $2M | $456.0K | |
| Accrued Liabilities | $7M | $4M | $6M | $4M | $3M | $4M | $5M | $5M | $3M | $4M | $3M | $3M | $2M | $1M | $3M | $2M | |
| Current Liabilities | $13M | $9M | $11M | $10M | $10M | $7M | $11M | $9M | $6M | $6M | $6M | $7M | $5M | $6M | $6M | $4M | |
| Capital Leases | $1M | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | |
| Total Liabilities | $15M | $11M | $13M | $12M | $13M | $10M | $14M | $12M | $10M | $10M | $11M | $12M | $10M | $12M | $11M | $9M | |
| Common Stock | $59.0K | $55.0K | $54.0K | $39.0K | $39.0K | $39.0K | $35.0K | $21.0K | $21.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | |
| Paid-in Capital | $503M | $502M | $499M | $417M | $416M | $415M | $412M | $314M | $313M | $270M | $269M | $267M | $266M | $264M | $263M | $261M | |
| Retained Earnings | $-342M | $-320M | $-302M | $-285M | $-272M | $-257M | $-245M | $-232M | $-221M | $-211M | $-200M | $-190M | $-180M | $-169M | $-160M | $-121M | |
| AOCI | $-363.0K | $-364.0K | $90.0K | $143.0K | $77.0K | $89.0K | $2.0K | $29.0K | · | $-1.0K | $-31.0K | $-165.0K | $-336.0K | $-469.0K | $-688.0K | $-1M | |
| Stockholders' Equity | $161M | $181M | $196M | $132M | $144M | $158M | $167M | $82M | $92M | $58M | $68M | $77M | $85M | $95M | $102M | $139M | |
| Liabilities + Equity | $176M | $192M | $209M | $145M | $157M | $169M | $181M | $94M | $102M | $68M | $79M | $88M | $95M | $106M | $113M | $149M | |
| Shares Outstanding | 59,083,935 | 55,055,582 | 53,587,260 | 38,587,260 | 38,581,863 | 38,577,813 | 35,044,772 | 20,629,772 | 11,364,903 | 11,433,837 | 11,364,903 | 11,364,903 | 11,307,962 | 11,306,753 | 11,267,389 | 11,267,389 |
Przepływy pieniężne 8
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $1M | $1M | $903.0K | $833.0K | $904.0K | $931.0K | $1M | $1M | $1M | $1M | $2M | $2M | $1M | $1M | |
| Operating Cash Flow | $-15M | $-21M | $-17M | $-12M | $-12M | $-15M | $-9M | $-8M | $-8M | $-10M | $-9M | $-7M | $-9M | $-13M | $-5M | $-5M | |
| CapEx | · | · | $24.0K | $4.0K | $22.0K | $44.0K | $0 | $8.0K | · | · | $0 | $37.0K | $2.0K | $6.0K | $6.0K | $83.0K | |
| Investing Cash Flow | $18M | $-15M | $-27M | $-7M | $-48M | $-58M | $22M | $-29M | $3M | $23M | $15M | $6M | $22M | $10M | $-18M | $19M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | $76.0K | · | $27.0K | $0 | $64.0K | $0 | $18.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $-76.0K | · | · | · | $-64.0K | · | · | |
| Financing Cash Flow | $-26.0K | $1M | $81M | $13.0K | $8.0K | $2M | $98M | $0 | $42M | $-76.0K | $0 | $-27.0K | $0 | $-64.0K | $0 | $-18.0K | |
| Free Cash Flow | · | · | · | · | · | $-15M | · | · | · | · | · | · | · | $-13M | · | · |
Rentowność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1575.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -1464.0% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1575.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -13.0% | -9.9% | · | -11.1% | -11.6% | -10.1% | · | -12.3% | -9.7% | -12.7% | · | -8.3% | -9.0% | -6.8% | · | -4.7% | |
| ROE | -14.2% | -10.5% | · | -12.4% | -12.7% | -11.0% | · | -14.1% | -10.7% | -14.5% | · | -9.1% | -9.8% | -7.3% | · | -5.0% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.0 | 15.7 | · | 13.7 | 12.8 | 18.0 | · | 9.8 | 16.3 | 10.5 | · | 11.5 | 17.1 | 14.8 | · | 26.6 | |
| Quick Ratio | 10.7 | 15.2 | · | 13.4 | 12.5 | 17.7 | · | 9.4 | 15.9 | 10.0 | · | 10.9 | 16.3 | 13.5 | · | 26.0 |
Efektywność 1
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 8
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-68M | $-58M | · | $-51M | $-48M | $-44M | · | $-42M | $-42M | $-41M | · | $-38M | $-37M | $-36M | · | $-38M | |
| Market Cap | $226M | $287M | · | $168M | $117M | $164M | · | $38M | $24M | $46M | · | $19M | $27M | $35M | · | $33M | |
| P/E | -2.9 | -4.1 | · | -3.0 | -1.9 | -1.9 | · | -0.7 | -0.6 | -1.1 | · | -0.5 | -0.7 | -1.0 | · | -0.9 | |
| P/B | 1.4 | 1.6 | · | 1.3 | 0.8 | 1.0 | · | 0.5 | 0.3 | 0.8 | · | 0.2 | 0.3 | 0.4 | · | 0.2 | |
| P / Tangible Book | 1.4 | 1.6 | · | 1.3 | 0.8 | 1.0 | · | 0.5 | 0.3 | 0.8 | · | 0.2 | 0.3 | 0.4 | · | 0.3 | |
| P / Cash Flow | · | -13.4 | · | · | · | -11.2 | · | · | · | -4.4 | · | · | · | -2.7 | · | · | |
| P / FCF | · | · | · | · | · | -11.1 | · | · | · | · | · | · | · | -2.7 | · | · | |
| Earnings Yield | -34.8% | -24.2% | · | -33.3% | -52.5% | -51.9% | · | -152.5% | -158.2% | -90.8% | · | -200.6% | -135.6% | -102.2% | · | -113.5% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Zysk netto | $-57M | $-45M | $-40M | $-66M | $-47M |
| Rozwodniony EPS | $-1.34 | $-2.17 | $-3.57 | $-5.86 | $-4.21 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 14.6 | 15.7 | 11.2 | 15.0 | 21.7 |
| Wskaźnik Szybkości | 14.2 | 15.5 | 10.7 | 14.7 | 21.2 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-56M | $-36M | $-38M | $-27M | $-35M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 127 emitentów · $162.3M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 31 (+4 vs poprzedni kw.) | 16 (-5 vs poprzedni kw.) | 39 (-8 vs poprzedni kw.) | 33 (+10 vs poprzedni kw.) | +760K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | $27 154 562 | 5 207 011 | 16,73% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $11 846 454 | 3 101 166 | 7,30% | Akcje |
| Velan Capital Investment Management LP | $10 866 571 | 2 844 652 | 6,70% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $8 786 508 | 2 300 133 | 5,41% | Akcje |
| Blackstone Inc. | $8 654 263 | 2 265 514 | 5,33% | Akcje |
| ORBIMED ADVISORS LLC | $8 480 400 | 2 220 000 | 5,23% | Akcje |
| Sio Capital Management, LLC | $7 341 551 | 1 921 872 | 4,52% | Akcje |
| ACORN CAPITAL ADVISORS, LLC | $6 693 079 | 1 752 115 | 4,12% | Akcje |
| Integral Health Asset Management, LLC | $5 730 000 | 1 500 000 | 3,53% | Akcje |
| 5AM Venture Management, LLC | $5 232 567 | 1 369 782 | 3,22% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $4 362 540 | 1 141 710 | 2,69% | Akcje |
| STATE STREET CORP | $4 080 887 | 1 068 295 | 2,51% | Akcje |
| Qube Research & Technologies Ltd | $3 993 871 | 1 045 516 | 2,46% | Akcje |
| Balyasny Asset Management L.P. | $3 921 960 | 1 026 691 | 2,42% | Akcje |
| BAKER BROS. ADVISORS LP | $3 711 565 | 971 614 | 2,29% | Akcje |
| ADAR1 Capital Management, LLC | $3 592 756 | 940 512 | 2,21% | Akcje |
| CITADEL ADVISORS LLC | $3 414 045 | 893 729 | 2,10% | Akcje |
| BANK OF AMERICA CORP /DE/ | $3 287 679 | 860 649 | 2,03% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $2 389 918 | 625 633 | 1,47% | Akcje |
| Point72 Asset Management, L.P. | $2 096 920 | 548 932 | 1,29% | Akcje |
| Catalio Capital Management, LP | $1 986 965 | 520 148 | 1,22% | Akcje |
| GOLDMAN SACHS GROUP INC | $1 936 106 | 506 834 | 1,19% | Akcje |
| Walleye Capital LLC | $1 930 750 | 505 432 | 1,19% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 878 130 | 491 657 | 1,16% | Akcje |
| MORGAN STANLEY | $1 833 917 | 480 083 | 1,13% | Akcje |
| UBS Group AG | $1 723 538 | 451 188 | 1,06% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $1 278 489 | 334 683 | 0,79% | Akcje |
| Verdad Advisers, LP | $1 192 791 | 312 249 | 0,73% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1 129 058 | 295 565 | 0,70% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $960 730 | 251 500 | 0,59% | Akcje |
| OPPENHEIMER & CO INC | $910 543 | 238 362 | 0,56% | Akcje |
| Jump Financial, LLC | $775 842 | 203 100 | 0,48% | Akcje |
| CIBC WORLD MARKET INC. | $636 011 | 166 495 | 0,39% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $603 449 | 157 971 | 0,37% | Akcje |
| J. Goldman & Co LP | $515 700 | 135 000 | 0,32% | Akcje |
| SUPERSTRING CAPITAL MANAGEMENT LP | $463 966 | 121 457 | 0,29% | Akcje |
| Fisher Asset Management, LLC | $380 342 | 99 566 | 0,23% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $376 220 | 98 487 | 0,23% | Akcje |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $325 961 | 85 330 | 0,20% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $266 071 | 69 652 | 0,16% | Akcje |
| FMR LLC | $260 012 | 68 066 | 0,16% | Akcje |
| XTX Topco Ltd | $244 281 | 63 948 | 0,15% | Akcje |
| RHUMBLINE ADVISERS | $241 589 | 63 245 | 0,15% | Akcje |
| TRUIST FINANCIAL CORP | $229 200 | 60 000 | 0,14% | Akcje |
| Assenagon Asset Management S.A. | $229 024 | 59 954 | 0,14% | Akcje |
| Trexquant Investment LP | $227 733 | 59 616 | 0,14% | Akcje |
| DEUTSCHE BANK AG\ | $220 464 | 57 713 | 0,14% | Akcje |
| ALPS ADVISORS INC | $217 897 | 57 041 | 0,13% | Akcje |
| AMERIPRISE FINANCIAL INC | $214 863 | 56 247 | 0,13% | Akcje |
| PRUDENTIAL FINANCIAL INC | $193 789 | 50 730 | 0,12% | Akcje |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $191 000 | 50 000 | 0,12% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $154 252 | 40 380 | 0,10% | Akcje |
| Alyeska Investment Group, L.P. | $151 753 | 39 726 | 0,09% | Akcje |
| Quadrature Capital Ltd | $150 199 | 39 319 | 0,09% | Akcje |
| Marex Group Ltd | $134 655 | 35 250 | 0,08% | Akcje |
| WINTON GROUP Ltd | $125 296 | 32 800 | 0,08% | Akcje |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $113 454 | 29 700 | 0,07% | Akcje |
| MetLife Investment Management, LLC | $108 404 | 28 378 | 0,07% | Akcje |
| MARSHALL WACE, LLP | $106 995 | 28 009 | 0,07% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $93 988 | 18 040 | 0,06% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $92 043 | 24 095 | 0,06% | Akcje |
| WOLVERINE TRADING, LLC | $88 200 | 20 000 | 0,05% | Opcja sprzedaży |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $87 478 | 22 900 | 0,05% | Opcja sprzedaży |
| CITIGROUP INC | $80 698 | 21 125 | 0,05% | Akcje |
| Jain Global LLC | $80 220 | 21 000 | 0,05% | Akcje |
| Invesco Ltd. | $78 295 | 20 496 | 0,05% | Akcje |
| Vanguard Global Advisers, LLC | $76 885 | 20 127 | 0,05% | Akcje |
| PRELUDE CAPITAL MANAGEMENT, LLC | $74 922 | 19 613 | 0,05% | Akcje |
| EntryPoint Capital, LLC | $73 673 | 19 286 | 0,05% | Akcje |
| LPL Financial LLC | $73 077 | 19 130 | 0,05% | Akcje |
| VANGUARD GROUP INC | $70 479 | 13 223 | 0,04% | Akcje |
| Squarepoint Ops LLC | $69 234 | 18 124 | 0,04% | Akcje |
| IEQ CAPITAL, LLC | $68 489 | 17 929 | 0,04% | Akcje |
| Police & Firemen's Retirement System of New Jersey | $67 114 | 17 569 | 0,04% | Akcje |
| BARCLAYS PLC | $60 665 | 15 881 | 0,04% | Akcje |
| BlackRock, Inc. | $58 950 | 15 432 | 0,04% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $56 834 | 14 878 | 0,04% | Akcje |
| INTECH INVESTMENT MANAGEMENT LLC | $51 807 | 13 562 | 0,03% | Akcje |
| WOLVERINE TRADING, LLC | $51 315 | 11 636 | 0,03% | Akcje |
| Mariner, LLC | $45 441 | 11 899 | 0,03% | Akcje |
| Bank of New York Mellon Corp | $43 877 | 11 486 | 0,03% | Akcje |
| VOYA INVESTMENT MANAGEMENT LLC | $43 812 | 11 469 | 0,03% | Akcje |
| D. E. Shaw & Co., Inc. | $42 452 | 11 113 | 0,03% | Akcje |
| COMMONWEALTH EQUITY SERVICES, LLC | $42 020 | 11 000 | 0,03% | Akcje |
| WELLS FARGO & COMPANY/MN | $41 161 | 10 775 | 0,03% | Akcje |
| Essential Partners LLC | $37 444 | 9 802 | 0,02% | Akcje |
| MERCER GLOBAL ADVISORS INC /ADV | $34 525 | 9 038 | 0,02% | Akcje |
| NORTHERN TRUST CORP | $32 061 | 8 393 | 0,02% | Akcje |
| CWM, LLC | $30 458 | 5 846 | 0,02% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $30 178 | 7 900 | 0,02% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $28 788 | 7 536 | 0,02% | Akcje |
| Tower Research Capital LLC (TRC) | $19 062 | 4 990 | 0,01% | Akcje |
| Legal & General Group Plc | $17 129 | 4 490 | 0,01% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $14 645 | 2 811 | 0,01% | Akcje |
| Ameritas Investment Partners, Inc. | $12 598 | 3 298 | 0,01% | Akcje |
| Nuveen, LLC | $9 642 | 2 524 | 0,01% | Akcje |
| Integrated Wealth Concepts LLC | $6 684 | 1 750 | 0,00% | Akcje |
| Arax Advisory Partners | $6 383 | 1 671 | 0,00% | Akcje |
| Russell Investments Group, Ltd. | $6 085 | 1 593 | 0,00% | Akcje |
| ROYAL BANK OF CANADA | $6 000 | 1 577 | 0,00% | Akcje |
Insiderzy spółki 40 insiderów · 16 dyrektorzy generalni · 20 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jesse Shefferman | CEO and President | 29 czerwca 2026 M | 691 832 | 0 | 1 | $-882 160 |
| Timothy P Noyes | President and CEO | 31 stycznia 2019 A | 0 | 0 | 0 | $0 |
| Patrick Fabbio | Chief Financial Officer | 26 stycznia 2026 F | 64 115 | 0 | 0 | $0 |
| Blaine Davis | Chief Financial Officer | 15 lipca 2022 F | 20 662 | 0 | 0 | $0 |
| George Arthur Eldridge, | Sr VP, CFO, Treasr, Asst Secy | 18 stycznia 2019 A | 29 132 | 0 | 0 | $0 |
| William Conkling | Chief Commercial Officer | 2 czerwca 2026 F | 69 992 | 0 | 0 | $0 |
| Jacqueline Zummo | Chief R&D Officer | 8 kwietnia 2026 S | 94 827 | 0 | 2 | $-124 989 |
| Hannah Fry | VP, Controller | 26 stycznia 2026 F | 42 723 | 0 | 0 | $0 |
| Leonardo Viana Nicacio | Chief Medical Officer | 16 stycznia 2026 A | 78 181 | 0 | 0 | $0 |
| Jathin Bandari | Chief Medical Officer | 19 stycznia 2024 A | 56 704 | 0 | 0 | $0 |
| Julio Casoy | Chief Medical Officer | 9 stycznia 2020 A | 45 500 | 0 | 0 | $0 |
| Steven Keith Burke | SVP and Chief Medical Officer | 15 marca 2019 G | 26 332 | 0 | 0 | $0 |
| Bradley J Hartman | VP, People | 18 stycznia 2019 A | — | 0 | 0 | $0 |
| Matthew Paul Kowalsky | VP, Legal and Secretary | 18 stycznia 2019 A | 29 479 | 0 | 0 | $0 |
| Scott E. Toner | Senior VP of Commercial | 18 stycznia 2019 A | 23 357 | 0 | 0 | $0 |
| Gottlieb Daniel Philip | VP Corporate Development | 18 stycznia 2019 A | 244 | 0 | 0 | $0 |
| Michael Edward Solomon | Dyrektor | 15 czerwca 2026 A | 26 500 | 0 | 0 | $0 |
| Jane Huang | Dyrektor | 15 czerwca 2026 A | — | 0 | 0 | $0 |
| Barry P Flannelly | Dyrektor | 15 czerwca 2026 A | — | 0 | 0 | $0 |
| Cynthia Smith | Dyrektor | 15 czerwca 2026 A | — | 0 | 0 | $0 |
| Richard S Levy | Dyrektor | 15 czerwca 2026 A | 51 000 | 0 | 0 | $0 |
| Roger Garceau | Dyrektor | 15 czerwca 2026 A | 33 000 | 0 | 0 | $0 |
| Gregory Sargen | Dyrektor | 15 czerwca 2026 A | 31 000 | 0 | 0 | $0 |
| Luke M Beshar | Dyrektor | 15 czerwca 2026 A | 198 000 | 0 | 0 | $0 |
| Scott Braunstein | Dyrektor | 9 czerwca 2020 A | 26 500 | 0 | 0 | $0 |
| John Gordon Freund | Dyrektor | 8 listopada 2019 C | 2 175 882 | 0 | 0 | $0 |
| Hubert Birner | Dyrektor | 8 czerwca 2018 A | 1 943 059 | 0 | 0 | $0 |
| Paul J Hastings | Dyrektor | 8 czerwca 2018 A | — | 0 | 0 | $0 |
| Scott A Canute | Dyrektor | 8 czerwca 2018 A | — | 0 | 0 | $0 |
| Garen G Bohlin | Dyrektor | 8 czerwca 2018 A | 53 312 | 0 | 0 | $0 |
| Jonathan S Leff | Dyrektor | 8 czerwca 2018 A | — | 0 | 0 | $0 |
| Brendan O'Leary | Dyrektor | 9 czerwca 2016 A | 1 387 198 | 0 | 0 | $0 |
| Dmitry Kobyzev | Dyrektor | 2 czerwca 2015 A | 1 165 344 | 0 | 0 | $0 |
| Gregory D Phelps | Dyrektor | 2 czerwca 2015 A | — | 0 | 0 | $0 |
| Opaleye, L.P. | Posiadacz 10% | 9 stycznia 2020 A | 2 208 472 | 0 | 0 | $0 |
| Martin Sebastian Olivo | — | 10 czerwca 2021 P | 14 344 | 0 | 0 | $0 |
| Randall Marshall | — | 14 września 2020 S | 585 600 | 0 | 0 | $0 |
| Timothy Haines | — | 12 listopada 2019 C | 2 144 517 | 0 | 0 | $0 |
| Abingworth LLP | — | 12 listopada 2019 C | 2 144 517 | 0 | 0 | $0 |
| Stuart A Kingsley | — | 8 czerwca 2018 A | — | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 8 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Deerfield Partners, L.P., Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Management Company, L.P., James E. Flynn | 8 stycznia 2021 | — | Pierwotne zgłoszenie | — | SEC |
| Opaleye Management Inc., Opaleye, L.P., James Silverman ×3 zgłoszenia | 25 września 2020 | — | Pierwotne zgłoszenie | — | SEC |
| Deerfield Special Situations Fund, L.P., Deerfield Partners, L.P., Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Management Company, L.P., James E. Flynn ×6 zgłoszenia | 17 stycznia 2020 | — | Pierwotne zgłoszenie | — | SEC |
| Abingworth LLP, Abingworth Bioventures VI, LP | 17 stycznia 2020 | — | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
| Abingworth LLP 98-051-8585, Abingworth Bioventures VI, LP 98-040-3543 ×3 zgłoszenia | 14 listopada 2019 | — | Pierwotne zgłoszenie | Kampania zarządu | SEC |
| TVM Life Science Ventures VI L.P., TVM Life Science Ventures VI GmbH & Co. KG, TVM Life Science Ventures Management VI L.P., Hubert Birner, Stefan Fischer, Helmut Schuehsler ×2 zgłoszenia | 2 sierpnia 2017 | — | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
| Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Mgmt III, L.P., Deerfield Special Situations Fund, L.P., Deerfield Partners, L.P., Deerfield International Master Fund, L.P., Deerfield Private Design Fund III, L.P., James E. Flynn | 29 czerwca 2017 | — | Pierwotne zgłoszenie | — | SEC |
| Skyline Venture Partners Qualified Purchaser Fund IV, L.P., Skyline Venture Management IV, LLC, John G. Freund, Yasunori Kaneko | 3 listopada 2014 | — | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 22 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0,16% | 55 748 NS | 31 maja 2026 | N-PORT |
| IWC · iShares Trust | 0,05% | 175 831 SH | 8 sierpnia 2026 | Dziennie |
| VFMO · VANGUARD WELLINGTON FUND | 0,03% | 141 979 SH | 8 sierpnia 2026 | Dziennie |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,02% | 91 844 NS | 31 maja 2026 | N-PORT |
| IWN · iShares Trust | 0,01% | 470 658 SH | 8 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 300 912 SH | 8 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 45 581 SH | 8 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,01% | 22 265 NS | 30 kwietnia 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1 336 607 SH | 8 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,01% | 179 929 NS | 30 kwietnia 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 2 419 NS | 31 maja 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 3 715 NS | 30 kwietnia 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 1 891 NS | 31 maja 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 1 912 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 48 NS | 31 maja 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 5 791 NS | 30 kwietnia 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 18 477 NS | 30 kwietnia 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 7 914 NS | 30 kwietnia 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 20 174 NS | 30 kwietnia 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 586 965 SH | 8 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 657 879 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 185 SH | 8 sierpnia 2026 | Dziennie |